Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study.

[1]  Borghi Claudio,et al.  Pulmonary Embolism in Patients with COVID-19 , 2022, Clinical Cardiology and Cardiovascular Interventions.

[2]  A. Cohen,et al.  Pulmonary embolism in COVID-19 patients: a French multicentre cohort study , 2020, European heart journal.

[3]  C. Helissey,et al.  Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department , 2020, European Radiology.

[4]  Jie Bao,et al.  Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19 , 2020, Clinica Chimica Acta.

[5]  M. Aepfelbacher,et al.  Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany , 2020, International Journal of Legal Medicine.

[6]  P. Wells,et al.  Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019 , 2020, Chest.

[7]  Jian-Ping Liu,et al.  Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients , 2020, Aging.

[8]  B. Trautner,et al.  Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill , 2020, JAMA network open.

[9]  A. Mebazaa,et al.  High Prevalence of Deep Vein Thrombosis in Mechanically Ventilated COVID-19 Patients , 2020, Journal of the American College of Cardiology.

[10]  Y. Arbel,et al.  Spectrum of Cardiac Manifestations in COVID-19 , 2020, Circulation.

[11]  A. Mebazaa,et al.  Excess out‐of‐hospital deaths during the COVID‐19 outbreak: evidence of pulmonary embolism as a main determinant , 2020, European journal of heart failure.

[12]  A. Lazo-Langner,et al.  Thrombosis risk associated with COVID-19 infection. A scoping review , 2020, Thrombosis Research.

[13]  J. Thachil,et al.  Coagulopathy of Coronavirus Disease 2019 , 2020, Critical care medicine.

[14]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[15]  P. Demelo-Rodríguez,et al.  Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism , 2020, Thrombosis Research.

[16]  V. Fuster,et al.  Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[17]  Mickaël Ohana,et al.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.

[18]  D. Gommers,et al.  Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis , 2020, Thrombosis Research.

[19]  F. Crea,et al.  COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options , 2020, Cardiovascular research.

[20]  J. Connors,et al.  COVID-19 and its implications for thrombosis and anticoagulation , 2020, Blood.

[21]  S. Susen,et al.  Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence. , 2020, Circulation.

[22]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[23]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[24]  Yutao Guo,et al.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up , 2020, Journal of the American College of Cardiology.

[25]  Feng Wang,et al.  Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[26]  A. Falanga,et al.  ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[27]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[28]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[29]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[30]  O. Rutschmann,et al.  Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. , 2014, JAMA.

[31]  A. Rauch,et al.  Pulmonary Embolism in Patients With COVID-19 Awareness of an Increased Prevalence Circulation , 2020 .